FDA data Registry peer set 5 peers FDA shortage listed

Alternatives to omeprazole

FDA shortage status is active for omeprazole; 5 same-class SPL records are listed below for registry comparison only.

Brand: Prilosec

Proton Pump Inhibitor (PPI) OTC 5 alternatives found

omeprazole class peers while FDA lists an active shortage

omeprazole (Prilosec) is on an FDA shortage listing while 5 other Proton Pump Inhibitor (PPI) SPL records remain in this registry peer set (class inventory 6). Labeled indication field for omeprazole: This medicine treats frequent heartburn, which is heartburn that occurs 2 or more days a week.

Top FAERS reaction fields for omeprazole total 155,765 reports across 10 reactions, set beside dexlansoprazole, esomeprazole, lansoprazole. Counts are exposure-weighted submissions, not per-patient risk.

About omeprazole

Omeprazole (Prilosec) is a medicine that reduces the amount of acid in your stomach. It belongs to a class of drugs called proton pump inhibitors (PPIs).

Used for: This medicine treats frequent heartburn, which is heartburn that occurs 2 or more days a week. It is not meant to give you immediate relief from heartburn. It may take 1 to 4 days for the medicine to fully work.

5 Proton Pump Inhibitor (PPI) peers (wide set)

Compare omeprazole vs dexlansoprazole side-by-side →

omeprazole vs dexlansoprazole & esomeprazole · FAERS reaction fields

FAERS top-reaction field "Fatigue" shows the widest count spread between omeprazole and dexlansoprazole, esomeprazole, lansoprazole in this extract (12,268-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect omeprazole dexlansoprazoleesomeprazolelansoprazole
Fatigue 19,901 2,337 3,528 7,633
Nausea 19,842 2,138 4,004 8,964
Diarrhoea 19,627 1,947 3,869 8,752
Dyspnoea 16,336 1,542 3,268 7,945
Headache 14,629 1,902 3,509 6,742
Pain 13,759 1,902 2,752 6,733
Chronic Kidney Disease 13,547 16,100 5,020 32,775
Vomiting 13,263 - 2,692 7,064

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

omeprazole shortage vs Proton Pump Inhibitor (PPI) peer index

Shortage status

FDA shortage listing is active for omeprazole (status: To Be Discontinued). Peer rows remain a registry index, not a switch guide.

Frequently Asked Questions

Does FDA list a shortage for omeprazole while peers remain indexed?
Yes - omeprazole matched an active FDA shortage listing (To Be Discontinued) while 5 other Proton Pump Inhibitor (PPI) SPL records remain in this peer index for field comparison only.

Registry note: Shortage listings and peer indexes are for registry orientation only. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full omeprazole profile →

Field note for omeprazole: see also the generic vs brand label guide when reading Prilosec SPL strings.